EV-based Liquid Biopsy Market Size, Share and Trends Analysis Report 2023-2031
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global EV-based Liquid Biopsy Market Size, Share & Trends Analysis Report By Offering (Kits & Assays, Instruments, Services), Workflow (Sample Preparation, Sequencing, Data Analysis), Application (Research Application & Clinical Application), Technology (Isolation Technologies and Detection Technologies), Sample Type (Blood (Plasma/Serum), Urine, Saliva, Other Biofluids (CF - Cerebrospinal fluid), Cell Culture), End User (Academic & Research Institutions, Clinical Laboratories, Pharmaceutical & Biotechnology Companies) Market Outlook And Industry Analysis 2031".The EV-based Liquid Biopsy Market Size is valued at 74.61 Million in 2022 and is predicted to reach 349.19 Million by the year 2031 at an 18.9% CAGR during the forecast period for 2023-2031..
Get A Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1920
Extracellular Vesicles (EVs) are released by every body cell, which is a snapshot of cellular biological activity. They can be in biofluids such as blood and provide the best way to detect and prevent non-invasive diseases, including cancer. EV-based liquid biopsy holds great promise for cancer diagnosis, prognosis and clinical monitoring. However, it is still necessary to provide precise EV subtype classification, standardized protocols, and larger patient cohort studies for further clinical translation.
Almost all EVs seen in the blood are from blood cells, such as platelets, red blood cells, or immune cells, and a small percentage are from tissues such as the liver, lungs, or kidneys. Conventional isolation techniques cannot distinguish between EVs based on their origin, thus limiting progress in disease biomarker discovery. Thus, many pharmaceutical companies are focusing on developing a novel and robust method to isolate tissue-specific EVs from blood to address these challenges.
Some of the prominent players in the EV-based Liquid Biopsy Market are:
• Abcam plc
• AMS Biotechnology Limited (AMSBIO)
• Bio-Techne Corporation
• Horiba Ltd.
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
• Lonza Group AG
• Malvern Panalytical Ltd
• Revvity, Inc. (PerkinElmer, Inc.)
• Takara Bio Inc.
• Emerging Companies
• Mursla Bio
• Nanostics Inc.
• Mercy BioAnalytics, Inc.
• Clara Diagnostics, Inc. (Clara Biotech)
• Other Prominent Players
EV-based Liquid Biopsy Market Report Scope
Report Attribute Specifications
Market Size Value In 2022 USD XX Million
Revenue Forecast In 2031 USD XX Million
Growth Rate CAGR CAGR of XX % from 2023 to 2031
Quantitative Units Representation of revenue in US$ Million and CAGR from 2023 to 2031
Historic Year 2019 to 2022
Forecast Year 2023-2031
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Offering, By Workflow, By Application, By Technology, By Sample Type, By End User
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1920
Competitive Landscape Abcam plc, AMS Biotechnology Limited (AMSBIO), Bio-Techne Corporation, Horiba Ltd., Qiagen N.V., Thermo Fisher Scientific, Inc., Lonza Group AG, Malvern Panalytical Ltd, Revvity, Inc. (PerkinElmer, Inc.), Takara Bio Inc., Emerging Companies, Mursla Bio, Nanostics Inc., Mercy BioAnalytics, Inc., Clara Diagnostics, Inc. (Clara Biotech), and others.
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing and Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.
Market Dynamics:
Drivers:
The increasing number of cancer cases is surging the demand for liquid biopsy.
The EV-based liquid biopsy market is mainly driven by the high prevalence of cancer and rising public awareness about the different non-invasive treatments.
As per the data provided by WCRF International (World Cancer Research Fund International), nearly 18.1 million cancer cases worldwide were reported in 2020. Thus, the high prevalence of cancer is expected to enhance the demand for EV-based liquid biopsy techniques during the forecast period.
Moreover, the increasing investments by market players in clinical trials to develop new diagnostic tests, high demand for personalized medicine, modifications in medical technologies, and growing R&D efforts in clinical oncology contribute to the market's growth.
Challenges:
However, the lack of standardized and clinically feasible EV purification & characterization protocols hinders the applicability of EV-based cancer biomarker analysis, which is expected to restrict the growth of the EV-based Liquid Biopsy Market in the coming years.
Regional Trends:
North America accounted for the maximum revenue share of the EV-based Liquid Biopsy Market in 2022. This is primarily due to the increasing prevalence of cancer in this region. In addition, growing demand for personalized therapies, increasing healthcare expenditure, and rising cancer research investments have boosted market growth. On the other hand, Asia Pacific is predicted to be the fastest-growing market over the forecast period. This is attributable to the increasing public awareness regarding liquid biopsy applications, well-established healthcare infrastructure, and rising adoption of advanced medical techniques in hospitals, clinics, and diagnostic laboratories for diagnosis.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1920
Key developments in the market:
• In May 2023, Mursla Bio discovered a new method in liquid biopsy and precision medicine to isolate tissue-specific extracellular vesicles (EVs) from the blood in addition to using a workflow to analyze their diverse multi-omics content.
• In March 2019, QIAGEN launched novel liquid biopsy solutions and NGS panels with seamlessly integrated bioinformatics to support advances in cancer research.
• In July 2018, Exosomics Siena S.p.A., a pioneer & world leader in exosome-based diagnostics, launched its first proprietary liquid biopsy solutions, SeleCTEV™ DNA and SortEV™ RNA, for the selective isolation of tumor-derived nucleic acids from complex biofluids such as plasma or serum.
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Offering
• Kits and Assays
• Instruments
• Services
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Workflow
• Sample Preparation
• Sequencing
• Data Analysis
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Application
• Research Application
• Clinical Application
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Technology
• Isolation Technologies
• Detection Technologies
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Sample Type
• Blood (Plasma/Serum)
• Urine
• Saliva
• Other Biofluids (CF - Cerebrospinal fluid)
• Cell Culture
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End User
• Academic and Research Institutions
• Clinical Laboratories
• Pharmaceutical and Biotechnology Companies
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031
• U.S.
• Canada
Europe EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa EV-based Liquid Biopsy Market Revenue (US$ Million) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global EV-based Liquid Biopsy Market
To receive an industry overview and future trends in the global EV-based Liquid Biopsy Market
To analyze the EV-based Liquid Biopsy Market drivers and challenges
To get information on the EV-based Liquid Biopsy Market size value (US$ Mn) forecast till 2031
Major Investments, Mergers & Acquisitions in the global EV-based Liquid Biopsy Market industry
For More Information: https://www.insightaceanalytic.com/report/ev-based-liquid-biopsy-market/1920
Other Related Reports Published by InsightAce Analytic:
https://www.insightaceanalytic.com/report/global-multi-cancer-early-detection-market/1408
https://www.insightaceanalytic.com/report/cancer-diagnostics-market/1726
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EV-based Liquid Biopsy Market Size, Share and Trends Analysis Report 2023-2031 here
News-ID: 3322854 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Bio
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
Global Bioplastics (Bio-plastics,Bio plastics) Market 2018 - Braskem, BASF
Apex Market Reports, recently published a detailed market research study focused on the “Bioplastics (Bio-plastics,Bio plastics) Market” across the global, regional and country level. The report provides 360° analysis of “Bioplastics (Bio-plastics,Bio plastics) Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Bioplastics…
Worldwide Bio-Electronics Market 2025 – Global Analysis and Forecasts by Type …
Bio-Electronics is defined as the electronic devices used for bio-medical purposes, and helps in creating and evaluating the new technologies for better understanding of biological systems. The increasing demand of bio-electronics to meet the overwhelming need in healthcare industry will boost the bio-electronics market in forecast period. Furthermore, the growth in research of implantable devices for developing robust and reliable implantable medical devices will increase the demand of bio-electronics in…
Bio Electronics and Bio Sensors Market Forecasts, 2017-2025
Description:
The global bio electronic market is valued USD $15 billion in 2016 and is expected to grow at a CAGR of 11.6% during the forecast period 2017-2025. The market is driven by various factors such as rapid advancement in semiconductor technology, high demand in implantable medical devices, increasing prevalence of neural and cardiac diseases among others. The emerging healthcare technologies such as lab on chip, ambulatory surgical centres, and personalized devices are…